HK:2552 Stock Latest News
Company AnnouncementsHua Medicine Grants Share Options to Senior Manager Under Incentive Scheme2M ago
Company AnnouncementsHua Medicine Accelerates Dorzagliatin Commercialization With Strong H1 2026 Growth2M ago
Company AnnouncementsHua Medicine Sets August Board Meeting to Approve Interim Results2M ago
Company AnnouncementsHua Medicine Issues Profit Warning as One-Off Bayer Gain Drops Out2M ago
Company AnnouncementsHua Medicine Shareholders Approve All AGM Resolutions, Renew Capital Mandates4M ago
Company AnnouncementsHua Medicine Sets New Board and Committee Line-Up Effective June 20264M agoCompany AnnouncementsHua Medicine Formalizes Nomination Committee Governance and Diversity Framework4M ago
Company AnnouncementsHua Medicine Strengthens Governance with New Nomination Committee Appointments4M ago
Company AnnouncementsHua Medicine Sets 2026 AGM to Approve Accounts and Renew Capital Mandates6M ago
Company AnnouncementsHua Medicine Seeks Shareholder Approval for Digital-Friendly Articles Update6M ago
Company AnnouncementsHua Medicine Doubles Diabetes Drug Revenue and Secures Hong Kong Approval for Dorzagliatin7M ago- Company AnnouncementsHua Medicine Reshuffles Company Secretary and Authorised Representative Roles7M ago
Company AnnouncementsHua Medicine Relocates Hong Kong Principal Place of Business7M ago
Company AnnouncementsHua Medicine Wins Hong Kong Approval for Pioneering Diabetes Drug Dorzagliatin8M ago
- Company AnnouncementsHua Medicine Advances Diabetes Treatment with New Phase Ib Trial10M ago
- Company AnnouncementsHua Medicine Grants Share Options to Drive Growth and Commitment11M ago
Company AnnouncementsHua Medicine Announces Changes to Remuneration Committee11M ago
Company AnnouncementsHua Medicine Updates Board of Directors and Committee Roles11M ago
Company AnnouncementsHua Medicine Reports Strong Growth in 20251y agoCompany AnnouncementsHua Medicine Reports Strong Growth and Strategic Advancements in 2025 Interim Results1y ago
